Human Growth Hormone Market Forecast to 2015
Since the launch of human insulin product, protein-based therapies have found a prominent place in the biopharmaceutical industry. According to our new research report on Human Growth Hormone (HGH) Market, the global protein therapeutics industry holds tremendous growth potential and is estimated to cross the US$ 143 Billion-mark by 2015-end. The market for HGH has expanded greatly in the past few years due to increase in the number of approved indications, and is expected to touch new heights in the coming years.
Our new research report, “Human Growth Hormone Market Forecast to 2015”, says that the future of the global HGH market entirely depends upon the success/failure of biosimilars. The extensive study also discusses how the patent expirations are affecting the revenue patterns of branded HGH products. It analyzes the market’s current scenario, and presents forecast on the basis of drivers, challenges and regulatory developments.
The in-depth research finds that the United States is the largest market for HGH, followed by Europe and Japan, which enjoy a combined market share of over 50%. Our comprehensive report also studies the competitive landscape in order to help clients understand the market structure and its dynamics. Overall, the work aims at presenting a complete and comprehensible picture of the global HGH market to the clients.
Our new research report, “Human Growth Hormone Market Forecast to 2015”, says that the future of the global HGH market entirely depends upon the success/failure of biosimilars. The extensive study also discusses how the patent expirations are affecting the revenue patterns of branded HGH products. It analyzes the market’s current scenario, and presents forecast on the basis of drivers, challenges and regulatory developments.
The in-depth research finds that the United States is the largest market for HGH, followed by Europe and Japan, which enjoy a combined market share of over 50%. Our comprehensive report also studies the competitive landscape in order to help clients understand the market structure and its dynamics. Overall, the work aims at presenting a complete and comprehensible picture of the global HGH market to the clients.
1. ANALYST VIEW
2. RESEARCH METHODOLOGY
3. GLOBAL PROTEIN THERAPEUTICS MARKET
3.1 Protein Therapeutics Market Vs Pharmaceutical Market
3.2 Current and Future Market Analysis to 2015
3.2.1 Market Segmentation
4. HUMAN GROWTH HORMONE MARKET FORECAST TO 2015
4.1 Scientific Insight
4.2 Current and Future Market Analysis to 2015
4.3 By Application
4.4 Key Geographical Markets
4.5 Key Players and Drugs
4.6 Recent Developments
5. KEY PLAYERS
5.1 Merck Serono S.A.
5.2 Pfizer
5.3 Novo Nordisk
2. RESEARCH METHODOLOGY
3. GLOBAL PROTEIN THERAPEUTICS MARKET
3.1 Protein Therapeutics Market Vs Pharmaceutical Market
3.2 Current and Future Market Analysis to 2015
3.2.1 Market Segmentation
4. HUMAN GROWTH HORMONE MARKET FORECAST TO 2015
4.1 Scientific Insight
4.2 Current and Future Market Analysis to 2015
4.3 By Application
4.4 Key Geographical Markets
4.5 Key Players and Drugs
4.6 Recent Developments
5. KEY PLAYERS
5.1 Merck Serono S.A.
5.2 Pfizer
5.3 Novo Nordisk
LIST OF FIGURES
Figure 3-1: Global - Protein Therapeutics vs Pharmaceutical Market (Billion US$), 2011
Figure 3-2: Global - Protein Therapeutics Market (Billion US$), 2011-2015
Figure 3-3: Global - Protein Therapeutics Market by Segment (%), 2011
Figure 3-4: Global - Forecast for Protein Therapeutics Market by Segment (%), 2015
Figure 4-1: Global - Human Growth Hormone Market (Billion US$), 2011-2015
Figure 4-2: US, Europe & Japan - Number of Patients with Pediatric Growth Hormone Deficiency (‘000)
Figure 4-3: Global - Share of Growth Hormones in Treatment of Pediatric Short Stature
Figure 4-4: Global - Adult Growth Hormone Deficiency Market (Million US$), 2011
Figure 4-5: US - Human Growth Hormone Market (Billion US$), 2009-2011
Figure 4-6: Europe - Human Growth Hormone Market (Billion US$), 2009-2011
Figure 4-7: Japan - Human Growth Hormone Market (Billion US$), 2009-2011
Figure 4-8: Global - Share of Key Players in Human Growth Hormone Market (2011)
Figure 3-1: Global - Protein Therapeutics vs Pharmaceutical Market (Billion US$), 2011
Figure 3-2: Global - Protein Therapeutics Market (Billion US$), 2011-2015
Figure 3-3: Global - Protein Therapeutics Market by Segment (%), 2011
Figure 3-4: Global - Forecast for Protein Therapeutics Market by Segment (%), 2015
Figure 4-1: Global - Human Growth Hormone Market (Billion US$), 2011-2015
Figure 4-2: US, Europe & Japan - Number of Patients with Pediatric Growth Hormone Deficiency (‘000)
Figure 4-3: Global - Share of Growth Hormones in Treatment of Pediatric Short Stature
Figure 4-4: Global - Adult Growth Hormone Deficiency Market (Million US$), 2011
Figure 4-5: US - Human Growth Hormone Market (Billion US$), 2009-2011
Figure 4-6: Europe - Human Growth Hormone Market (Billion US$), 2009-2011
Figure 4-7: Japan - Human Growth Hormone Market (Billion US$), 2009-2011
Figure 4-8: Global - Share of Key Players in Human Growth Hormone Market (2011)
LIST OF TABLES
Table 4-1: Global - Key Players and Drugs in Human Growth Hormone Market (Million US$), 2011
Table 5-1: Merck Serono - Key Products in Protein Therapeutics
Table 5-2: Pfizer Inc. - Key Products in Protein Therapeutics
Table 5-3: Novo Nordisk - Key Products in Protein Therapeutics
Table 4-1: Global - Key Players and Drugs in Human Growth Hormone Market (Million US$), 2011
Table 5-1: Merck Serono - Key Products in Protein Therapeutics
Table 5-2: Pfizer Inc. - Key Products in Protein Therapeutics
Table 5-3: Novo Nordisk - Key Products in Protein Therapeutics
